Cargando…
The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years
Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular r...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801508/ https://www.ncbi.nlm.nih.gov/pubmed/35111829 http://dx.doi.org/10.3389/fcvm.2021.809580 |
_version_ | 1784642476504514560 |
---|---|
author | Wu, Chan Liu, Binghong Wang, Ruiying Li, Gang |
author_facet | Wu, Chan Liu, Binghong Wang, Ruiying Li, Gang |
author_sort | Wu, Chan |
collection | PubMed |
description | Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular reflow by treatment, and severe ones can lead to heart failure or even death. In recent years, several studies have shown that microRNAs (miRNAs), playing a regulatory role in damaged hearts, bring light for patients to alleviate MI. In this review, we summarized the effect of miRNAs on MI with some mechanisms, such as apoptosis, autophagy, proliferation, inflammatory; the regulation of miRNAs on cardiac structural changes after MI, including angiogenesis, myocardial remodeling, fibrosis; the application of miRNAs in stem cell therapy and clinical diagnosis; other non-coding RNAs related to miRNAs in MI during the past 5 years. |
format | Online Article Text |
id | pubmed-8801508 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-88015082022-02-01 The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years Wu, Chan Liu, Binghong Wang, Ruiying Li, Gang Front Cardiovasc Med Cardiovascular Medicine Myocardial infarction (MI) is the most frequent end-point of cardiovascular pathology, leading to higher mortality worldwide. Due to the particularity of the heart tissue, patients who experience ischemic infarction of the heart, still suffered irreversible damage to the heart even if the vascular reflow by treatment, and severe ones can lead to heart failure or even death. In recent years, several studies have shown that microRNAs (miRNAs), playing a regulatory role in damaged hearts, bring light for patients to alleviate MI. In this review, we summarized the effect of miRNAs on MI with some mechanisms, such as apoptosis, autophagy, proliferation, inflammatory; the regulation of miRNAs on cardiac structural changes after MI, including angiogenesis, myocardial remodeling, fibrosis; the application of miRNAs in stem cell therapy and clinical diagnosis; other non-coding RNAs related to miRNAs in MI during the past 5 years. Frontiers Media S.A. 2022-01-17 /pmc/articles/PMC8801508/ /pubmed/35111829 http://dx.doi.org/10.3389/fcvm.2021.809580 Text en Copyright © 2022 Wu, Liu, Wang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cardiovascular Medicine Wu, Chan Liu, Binghong Wang, Ruiying Li, Gang The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title | The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title_full | The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title_fullStr | The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title_full_unstemmed | The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title_short | The Regulation Mechanisms and Clinical Application of MicroRNAs in Myocardial Infarction: A Review of the Recent 5 Years |
title_sort | regulation mechanisms and clinical application of micrornas in myocardial infarction: a review of the recent 5 years |
topic | Cardiovascular Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801508/ https://www.ncbi.nlm.nih.gov/pubmed/35111829 http://dx.doi.org/10.3389/fcvm.2021.809580 |
work_keys_str_mv | AT wuchan theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT liubinghong theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT wangruiying theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT ligang theregulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT wuchan regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT liubinghong regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT wangruiying regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years AT ligang regulationmechanismsandclinicalapplicationofmicrornasinmyocardialinfarctionareviewoftherecent5years |